Investigating Axonal Damage in Multiple Sclerosis by Diffusion Tensor Spectroscopy
Emily T. Wood(National Institutes of Health), Daniel S. Reich(National Institutes of Health), Aranee Techawiboonwong(Mahidol University), Peter B. Barker(Johns Hopkins University), Itamar Ronen(Leiden University), Daniel M. Harrison(University of Maryland, Baltimore), Peter A. Calabresi(Johns Hopkins University), Craig Jones(Johns Hopkins University)
Cited by 70
Related Papers
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines
|The Lancet Neurology|2016|863
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
|The Lancet|2011|743
2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis
|The Lancet Neurology|2021|646
Multiple sclerosis progression: time for a new mechanism-driven framework
|The Lancet Neurology|2022|624